drugset / Trial / NCT00978172
Safety and Efficacy Study of Artesunate and Mefloquin in Children With Uncomplicated Malaria
Phase 4
Completed
220 enrolled
Mepha Ltd.
Centre Mère et Enfant de la Fondation Chantal Biya · collab
NaSingle-groupOpen-labelTreatment
Summary
The present study aims to investigate and to assess possible neurological and neuropsychiatric events in young children in west Africa with uncomplicated P. falciparum malaria after a 3-day treatment of Artequin Paediatric under "real life conditions."
Timeline
- Start
- 2007-12
- Primary completion
- —
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Artesunate | Small molecule | 50 mg | Oral |
| Subject | Mefloquine | Unknown | 125 mg | Oral |